Huashan Hospital
Shanghai, Shanghai Municipality, 200000, China
NCT Number: NCT06664190
Pituitary adenomas (PAs) are among the most prevalent lesions of the sella turcica, accounting for 10%-25% of all intracranial neoplasms. Pituitary macroadenomas (PMAs) are defined with a maximum diameter of over 1 cm. Tumor characteristics are key factors influencing surgical effectiveness and complications of PMAs, with tumor perfusion and consistency identified as major predictive factors in literature. Conventional sequences provide limited information for predicting the perfusion and consistency of pituitary adenomas. Advanced sequences offer additional insights. However, the efficacy of combining radiomic features from multiparametric sequences, incorporating both conventional and advanced sequences, has not yet been proved.
We aim to develop machine learning models that combines radiomic features developed from both conventional and advanced sequences to predict the perfusion and consistency of PMAs. Furthermore, we aim to demonstrate the clinically applicability of these models by constructing a MR-PIT stratification (Multiparametric Radiomic derived and tumor Perfusion and consIsTency based surgical difficulty stratification), which correlated with the surgical strategy and outcomes.
This study is active but is not currently recruiting participants.
All sexes
Observational
Shanghai, Shanghai Municipality, 200000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Advanced sequences, such as arterial spin labeling (ASL) and diffusion-weighted imaging (DWI)
Time frame: From enrollment to the end of treatment at 12 weeks
Time frame: From enrollment to the end of treatment at 12 weeks
Huashan Hospital
Other
Study on Preoperative Imaging for Precise Prediction of Surgical Difficulty, Efficacy, and Risks in Pituitary Adenoma Surgeries
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03583528
Adenocarcinoma, Adenoma
Vancouver, British Columbia, Canada
View Trial DetailsNCT03465618
Brain Cancer, Brain Diseases
New York, United States
View Trial DetailsNCT07446036
Brain Diseases, Brain Neoplasms
Beijing, Fengtai, China
View Trial DetailsNCT00001452
Abnormalities, Multiple, Adrenal Gland Diseases
Bethesda, Maryland, United States
View Trial Details